Not logged in.png)
Share.png)
SaveShare Save Exploration of the development of a food safety risk index system for chemical contamination of aquatic products
Liu, Qiqi; Ou, Yijun; Florence, Mhungu; Li, Yan; Wang, Yanyan; Zhang, Yuhua; Liu, Lan; Lei, Jiangbo; Huang, Lili; Wu, Sixuan; Peng, Rongfei; Bai, Zhijun; Zhang, Weiwei Share Save The impact of small food workshops management regulations on aflatoxin B1 in home-made peanut oil and the liver function of high-consumption area residents: an interrupted time series study in Guangzhou, ChinaLei, Jiangbo; Li, Yan; Wang, Yanyan; Zhou, Jinchang; Wu, Yuzhe; Zhang, Yuhua; Liu, Lan; Ou, Yijun; Huang, Lili; Wu, Sixuan; Guo, Xuanya; Liu, Lieyan; Peng, Rongfei; Bai, Zhijun; Zhang, Weiwei Share Save Immune Persistence following Primary Immunization and the Immunogenicity and Safety of a Booster Dose of a Multidose Sabin Strain-Based Inactivated Polio Vaccine in Infants Aged 18 MonthsFeng, Guangwei; Shao, Ming; Wang, Jianfeng; Huang, Lili; Tan, Jian; Jiang, Zhiwei; You, Wangyang; Li, Yurong; Yang, Yonghui; Li, Jing; Wang, Yanxia Share Save Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10-50 years old: Randomized, blinded, parallel controlled phase III clinical studyHuang, Xiaoyuan; Liang, Jing; Huang, Lili; Nian, Xuanxuan; Chen, Wei; Zhang, Jiayou; Xu, Xiao; Lin, Xuan; Wang, Yue; Shi, Jinrong; Jia, Lanxin; Li, Qingliang; Wang, Qianxi; Duan, Kai; Li, Xinguo; Ji, Yaqi; Peng, Feixia; Zhang, Wei; Xie, Zhiqiang; Wang, Yanxia; Yang, Xiaoming Share Save Immunogenicity and Safety of a Booster Dose of Live Attenuated Varicella Vaccine, and Immune Persistence of a Primary Dose for Children Aged 2 to 6 YearsZhang, Yukai; Wang, Lei; Wang, Yanxia; Zhang, Wei; Jia, Ningning; Xie, Zhiqiang; Huang, Lili; You, Wangyang; Lu, Weifeng; Li, Erwei; Gao, Feilong; Hu, Yuansheng; Meng, Fanhong; Xia, Shengli Share Save Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trialXia, ShengLi; Zhang, YunTao; Wang, YanXia; Wang, Hui; Yang, YunKai; Gao, George Fu; Tan, WenJie; Wu, GuiZhen; Xu, Miao; Lou, ZhiYong; Huang, WeiJin; Xu, WenBo; Huang, BaoYing; Wang, Wei; Zhang, Wei; Li, Na; Xie, ZhiQiang; Zhu, Xiujuan; Ding, Ling; You, WangYang; Zhao, YuXiu; Zhao, Jun; Huang, LiLi; Shi, XueZhong; Yang, YongLi; Xu, GuangXue; Wang, WenLing; Liu, PeiPei; Ma, Meng; Qiao, YuLing; Zhao, SuHua; Chai, JingJing; Li, QinQin; Fu, Hui; Xu, Ying; Zheng, XiaoTong; Guo, WanShen; Yang, XiaoMing Share Save Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trialGuo, Wanshen; Duan, Kai; Zhang, Yuntao; Yuan, Zhiming; Zhang, Yan-Bo; Wang, Zejun; Zhao, Dongyang; Zhang, Huajun; Xie, Zhiqiang; Li, Xinguo; Peng, Cheng; Zhang, Wei; Yang, Yunkai; Chen, Wei; Gao, Xiaoxiao; You, Wangyang; Wang, Xue-Wei; Shi, Zhengli; Wang, Yanxia; Yang, Xu-Qin; Zhang, Lianghao; Huang, Lili; Wang, Qian; Lu, Jia; Yang, Yong-Li; Guo, Jing; Zhou, Wei; Wan, Xin; Wu, Cong; Wang, Wenhui; Du, Jianhui; Nian, Xuanxuan; Li, Xing-Hang; Huang, Shihe; Shen, Shuo; Xia, Shengli; Pan, An; Yang, Xiaoming Share Save Safety and immunogenicity of an alum-adjuvanted whole-virion H7N9 influenza vaccine: a randomized, blinded, clinical trialWang, Shilei; Xie, Zhiqiang; Huang, Lili; Zhou, Xu; Luo, Jian; Yang, Yuelian; Li, Changgui; Duan, Peng; Xu, Wenting; Chen, Dandan; Wu, Bing; Yang, Yongli; Liu, Xueying; Wang, Yanxia; Yuan, Zhenghong; Qu, Di; Chen, Ze; Xia, Shengli Share Save Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trialXia, Shengli; Zhang, Yuntao; Wang, Yanxia; Wang, Hui; Yang, Yunkai; Gao, George Fu; Tan, Wenjie; Wu, Guizhen; Xu, Miao; Lou, Zhiyong; Huang, Weijin; Xu, Wenbo; Huang, Baoying; Wang, Huijuan; Wang, Wei; Zhang, Wei; Li, Na; Xie, Zhiqiang; Ding, Ling; You, Wangyang; Zhao, Yuxiu; Yang, Xuqin; Liu, Yang; Wang, Qian; Huang, Lili; Yang, Yongli; Xu, Guangxue; Luo, Bojian; Wang, Wenling; Liu, Peipei; Guo, Wanshen; Yang, Xiaoming Share Save Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes Interim Analysis of 2 Randomized Clinical TrialsXia, Shengli; Duan, Kai; Zhang, Yuntao; Zhao, Dongyang; Zhang, Huajun; Xie, Zhiqiang; Li, Xinguo; Peng, Cheng; Zhang, Yanbo; Zhang, Wei; Yang, Yunkai; Chen, Wei; Gao, Xiaoxiao; You, Wangyang; Wang, Xuewei; Wang, Zejun; Shi, Zhengli; Wang, Yanxia; Yang, Xuqin; Zhang, Lianghao; Huang, Lili; Wang, Qian; Lu, Jia; Yang, Yongli; Guo, Jing; Zhou, Wei; Wan, Xin; Wu, Cong; Wang, Wenhui; Huang, Shihe; Du, Jianhui; Meng, Ziyan; Pan, An; Yuan, Zhiming; Shen, Shuo; Guo, Wanshen; Yang, Xiaoming Share Save Efficacy, safety and immunogenicity of live attenuated varicella vaccine in healthy children in China: double-blind, randomized, placebo-controlled clinical trialHao, B.; Chen, Z.; Zeng, G.; Huang, L.; Luan, C.; Xie, Z.; Chen, J.; Bao, M.; Tian, X.; Xu, B.; Wang, Y.; Wu, J.; Xia, S.; Yuan, L.; Huang, J. Share Save Safety, immunogenicity, and lot-to-lot consistency of live attenuated varicella vaccine in 1-3 years old children: a double-blind, randomized phase III trialHuang, Lili; Chen, Zhen; Hu, Yuansheng; Xie, Zhiqiang; Qiu, Ping; Zhu, Lang; Bao, Manli; Quan, Yaru; Zeng, Ji; Wang, Yanxia; Cui, Xiaoyu; Yuan, Liyong; Xia, Shengli; Meng, Fanhong Share Save A phase III clinical trial to evaluate the safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine (PPV23) in healthy children, adults, and elderlyHuang, Lili; Wang, Ling; Li, Hong; Hu, Yuansheng; Ru, Weiping; Han, Weixiao; Shi, Gang; Ye, Qiang; Han, Zhen; Xia, Jielai; Xia, Shengli; Xu, Miao; Li, Jing Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
